Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX:LDSYF), (Frankfurt:LD6, WKN:A14XHT) (“LDS” or the “Company”) announces it has entered into an exclusive agreement to negotiate a proposed business amalgamation between TransCanna Holdings Inc. (CSE:TCAN, XETR:TH8) (“TransCanna”, or “TCAN”) and Lifestyle Delivery Systems Inc. The proposed business amalgamation is expected to involve the acquisition by TransCanna of all the outstanding common shares of LDS at a price equal to the greater of $51,660,140payable in common shares of TransCanna and the amount resulting from a fixed exchange ratio of one (1) TransCanna common shares for every ten (10) LDS common shares.

This transaction, if completed, would allow for the operational foundation created by LDS to be expanded into the TCAN northern California facility in a significant way. In this new entity the TCAN-known cannabis brands with LDS expertise could have a potential to be cultivated, processed, manufactured and taken direct to market almost immediately upon closing of this transaction. The shareholders of LDS will receive a premium on the current price, while being protected from any downside pricing risk between the day of this news release and the closing date by the purchase price floor of $51,660,140 (which can be greater but not less) and the fixed share exchange ratio of 10:1 LDS shares for TCAN shares. TCAN management has been successful in their ability to promote and deliver to the market a comprehensive vision of the value of a vertically-integrated California cannabis operation. This transaction would make that vision a reality the day it closes. There are a number of transaction qualifications required before this decision goes to the shareholders. The due diligence by both companies, a fairness opinion and the approval from the Securities Exchange Commission. Ultimately the shareholders will determine the final decision of whether or not the amalgamation will be completed.


The Company’s CEO, Brad Eckenweiler, stated, “We believe that the amalgamation of our two companies will ultimately yield a value greater than the current individual values of LDS and TCAN. During the coming months, I believe the benefit of this transaction will become apparent to all the parties. The transaction will require approximately 60 days to structure and its closing will be subject to the approval of the Securities Exchange Commission, a fairness opinion, due diligence and the shareholders’ approval. During the estimated 60-day period the shareholders will have ample time to decide for themselves as to the value of this transaction. Moreover, there is no single group, brokerage or the management for LDS that have a percentage of ownership that would constitute a majority interest capable of deciding this issue alone. This transaction will be decided by the shareholders, period.”

The Company will continue to update the market on all events as they become relevant.

About Lifestyle Delivery Systems Inc.

Lifestyle Delivery Systems Inc. is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to other forms of delivery but also superior bioavailability of cannabis constituents. Some strips will also include supplemental co-active ingredients such as nutraceuticals, vitamins and peptides. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. From start to finish, the production process, based on the Company’s technology, tests for quality and composition of all the ingredients used in each and every strip which results in a delivery system that is safe, consistent and effective.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

Lifestyle Delivery Systems Inc.
Brad Eckenweiler
CEO & Director

FOR MORE INFORMATION, PLEASE CONTACT:
information@lifestyledeliverysystems.com

Cautionary Disclaimer Statement:

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970.  Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect.  Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.

Click here to connect with Transcanna Holdings Inc. (CSE:TCAN) for an Investor Presentation.

Source: www.prnewswire.com

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less